The largest database of trusted experimental protocols

Prism 8.3.0 for macos

Manufactured by GraphPad
Sourced in United States

GraphPad Prism 8.3.0 for MacOS is a data analysis and graphing software. It provides tools for organizing, analyzing, and visualizing scientific data. The software is designed to run on MacOS operating systems.

Automatically generated - may contain errors

8 protocols using prism 8.3.0 for macos

1

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analysis was performed using GraphPad Prism 8.3.0 for MacOS (GraphPad Software, Inc. La Jolla, CA, USA). The distribution of the obtained results was assessed using the Shapiro–Wilk test. Due to the lack of normal distribution, the Mann–Whitney U test was used for quantitative comparisons. Chi-square test with Yates’s modification was used to analyze the differences in the prevalence of qualitative variables. Correlations of the results were assessed using the Spearman rank correlation coefficient. The statistical significance level was set at p < 0.05.
The number of subjects was determined based on our previous experiment, assuming that the power of the test would be equal to 0.9 (ClinCalc sample size calculator).
+ Open protocol
+ Expand
2

Redox Biomarkers Diagnostic Utility

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analysis was performed using GraphPad Prism 8.3.0 for MacOS (GraphPad Software, Inc. La Jolla, USA). The normality of the distribution was assessed using the Shapiro–Wilk test. For comparison of quantitative variables, the Kruskal–Wallis ANOVA test and Dunn’s test were used. Multiplicity adjusted p-value was also calculated. The relationship between the assessed redox biomarkers was evaluated using the Spearman rank correlation. In order to determine the diagnostic utility of measured parameters, receiver operating characteristic (ROC) curves were drawn, and the area under the curve (AUC) was calculated. The statistical significance level was set at p < 0.05.
The number of subjects was determined based on our previous experiment, assuming that the power of the test would be equal to 0.9.
+ Open protocol
+ Expand
3

Hemolysis Protection by A1M

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was drawn from a voluntary 30 y/o female donor (according to permit from Ethical Review Board in Lund: Dnr. 2015/801) in K2EDTA-coated vacutainers (BD, Franklin Lakes, NJ, USA). The blood was transferred to a Falcon tube and centrifuged (800×g, 10 min) for blood fractionation. The RBCs were washed five times with PBS (pH 7.4) and afterwards diluted in PBS to 1% suspension (v/v). Thereafter, RBCs were incubated in 1.5 ml Eppendorf tubes for spontaneous hemolysis with increasing concentrations of HS6 (3.5, 14, 56, 225 or 1000 μg/ml) with or without recombinant A1M (220 μg/ml) or PBS in control samples. After 5 h of incubation in room temperature (end-over-end rotation, 8 rpm) the tubes were centrifuged (500×g, 5 min) and the supernatants were used for analysis of lactate dehydrogenase (LDH). The LDH release was measured with the CytoTox 96® Non-Radio Cytotoxicity Assay (Promega, Madison, WI, USA) according to instructions from the manufacturer. The absorbance was measured at 490 nm (VICTOR 1420 multilabel reader, PerkinElmer). Results are presented as a protection ratio where addition of only A1M is set to 1. Statistical comparison of differences was performed with a Kruskal-Wallis test with Dunn's multiple comparisons test using GraphPad Prism 8.3.0 for MacOS (GraphPad, Bethesda, MD, USA).
+ Open protocol
+ Expand
4

Glycation Assay Statistical Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The results were expressed as a percentage of the corresponding control values (BSA + glycating agent). Differences between groups were assessed by one-way ANOVA followed by Tukey’s post-hoc test for multiple comparisons. p < 0.05 was considered to be statistically significant. Multiplicity adjusted p value was also calculated. The analysis was conducted using the statistical package: GraphPad Prism 8.3.0 for MacOS (GraphPad Software, La Jolla, CA, USA).
+ Open protocol
+ Expand
5

Assessing Redox Biomarkers Relationship

Check if the same lab product or an alternative is used in the 5 most similar protocols
The statistical significance level was set at p < 0.05. The normality of the distribution was assessed using the Shapiro–Wilk test, while homogeneity of variance used the Levene test. For comparison of quantitative variables, the Kruskal–Wallis ANOVA test and Dunn's posthoc test were used. Multiplicity adjusted p value was also calculated. The relationship between the assessed redox biomarkers was evaluated using the Spearman rank correlation. Statistical analysis was performed using GraphPad Prism 8.3.0 for macOS (GraphPad Software, Inc. La Jolla, USA).
The number of subjects was determined based on our previous experiment, assuming that the test's power would be equal to 0.9 (online ClinCalc sample size calculator).
+ Open protocol
+ Expand
6

Nitrosative Stress Biomarkers Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
GraphPad Prism 8.3.0 for MacOS (GraphPad Software, Inc. La Jolla, USA) was used to statistical data processing. The normality of the distribution was assessed using the Shapiro–Wilk test. Characteristics of data sets were presented by the method of descriptive analysis. For comparison of quantitative variables, ANOVA Kruskal–Wallis and Dunn's test were used. The statistical significance was set at p < 0.05. Multiplicity adjusted p value was also calculated. The association between nitrosative stress biomarkers was evaluated using the Spearman rank correlation. The diagnostic usefulness of assessed biomarkers was determined by receiver operating characteristic (ROC) analysis. The number of patients was calculated a priori based on our previous experiment. The power of the test was 0.9 (ClinCalc online calculator).
+ Open protocol
+ Expand
7

Statistical Analysis of Quantitative Variables

Check if the same lab product or an alternative is used in the 5 most similar protocols
GraphPad Prism 8.3.0 for MacOS (GraphPad Software, Inc., La Jolla, CA, USA) was used for statistical analysis. Normality of distribution was assessed using the Shapiro-Wilk test. For comparison of the quantitative variables, one-way analysis of variance (ANOVA) followed by the Tukey post hoc test was used. The statistical significance level was established at P<0.05
+ Open protocol
+ Expand
8

Diagnostic Utility of Salivary/Plasma Cytokines

Check if the same lab product or an alternative is used in the 5 most similar protocols
GraphPad Prism 8.3.0 for MacOS (GraphPad Software, Inc. La Jolla, USA) was used for statistical analysis. The normality of the distribution was assessed using the Shapiro–Wilk test. For comparison of the quantitative variables, Mann–Whitney U test was used. The statistical significance level was established at p < 0.05. The relationship between the assessed parameters was evaluated using the Spearman rank correlation coefficient. In order to determine the diagnostic utility of salivary/plasma cytokines, receiver operating characteristic (ROC) curves were drawn, and the area under the curve (AUC) was calculated. Multivariate analysis of the simultaneous impacts of many independent variables on one quantitative dependent variable was made by the means of linear regression. HT duration, TPO-Ab, TPO-AB, UWS flow, and CODS were included as independent variables. The number of subjects in the groups was determined based on our previous experiment, assuming that the power of the test was 0.9 and α = 0.05. The ClinCalc online calculator was used, and the minimum number of participants per group was 21.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!